Outcome domains for studies of acute and chronic gout

Journal of Rheumatology

Volumn 36, Issue 10, 2009, Pages 2342-2345

  Schumacher, H Ralph ^a   Taylor, William ^b   Edwards, Lawrence ^c   Grainger, Rebecca ^b,c,d   Schlesinger, Naomi ^e   Dalbeth, Nicola ^f   Sivera, Francisca ^m   Singh, Jasvinder ^g,h   Evans, Robert ⁱ   Waltrip, Royce W ^j   Diaz Torne, Cesar ^k   Macdonald, Patricia ^l   Mcqueen, Fiona ^f   Perez Ruiz, Fernando ^m  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^e ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF AUCKLAND   (New Zealand)

^g HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^h VA MEDICAL CENTER   (United States)

ⁱ REGENERON PHARMACEUTICALS INC   (United States)

^j Savient Pharmaceuticals   (United States)

^k HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^l Takeda Pharmaceuticals Research and Development Center Inc   (United States)

^m HOSPITAL DE CRUCES   (Spain)

more..

Author keywords

Clinical trials; Gout; Omeract; Outcome measures

Indexed keywords

URIC ACID;

ACUTE DISEASE; CHRONIC DISEASE; CLINICAL ASSESSMENT; CONFERENCE PAPER; GOUT; HUMAN; INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH; JOINT SWELLING; OUTCOME ASSESSMENT; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; URIC ACID BLOOD LEVEL;

ACUTE DISEASE; ARTHRALGIA; CHRONIC DISEASE; CONSENSUS; DISABILITY EVALUATION; GOUT; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; URIC ACID;

EID: 70349228754     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090370     Document Type: Conference Paper

References (12)

1. Martinon F, Pétrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;44:237-241. (Pubitemid 43372104)
2. Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, et al. AF.SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 2008;40:437-442.
3. Chang SJ, Chen CJ, Tsai FC, Lai HM, Tsai PC, Tsai MH, Ko YC. Associations between gout tophus and polymorphisms 869T/C and -509C/T in transforming growth factor beta1 gene. Rheumatology 2008;47:617-621.
4. Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005;353:2450-2461. (Pubitemid 41781828)
5. Sherman MR, Saifer MG, Perez-Ruiz F. PEG-uricase in the management of treatment-resistant gout and hyperuricemia. Adv Drug Deliv Rev 2008;60:59-68. (Pubitemid 350186186)
6. Schumacher HR Jr, Edwards LN, Perez-Ruiz F, Becker M, Chen LX, Furst DE, et al. OMERACT 7 Special Interest Group. Outcome measures for acute and chronic gout. J Rheumatol 2005;32:2452-2455.
7. Schumacher HR, Taylor W, Joseph-Ridge N, Perez-Ruiz F, Chen LX, Schlesinger N, et al. Outcome evaluations in gout. J Rheumatol 2007;34:1381-1385.
8. Taylor WJ, Schumacher HR Jr, Baraf HS, Chapman P, Stamp L, Doherty M, et al. A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout. Ann Rheum Dis 2008;67:888-891. (Pubitemid 351829395)
9. World Health Organization. International Classification of Functioning, Disability and Health. Geneva: WHO; 2001.
10. Cieza A, Ewert T, Ustun TB, Chatterjee S, Kostanjsek N, Stucki G. Development of ICF Core Sets for patients with chronic conditions. J Rehabil Med 2004;Suppl 44:9-11 (Pubitemid 39307105)
11. Grill E, Zochling J, Stucki G, Mittrach R, Scheuringer M, Liman W, et al. International Classification of Functioning, Disability and Health (ICF). Core set for patients with acute arthritis. Clin Exp Rheumatol 2007;25:252-258.
12. Grainger R, Taylor W, Dalbeth N, Perez-Ruiz F, Singh JA, Waltrip RW, et al. Progress in measurement instruments for acute and chronic gout studies. J Rheumatol 2009;36:2346-2355.